STOCK TITAN

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Champions Oncology, Inc. (CSBR) will report its financial and operational results for the second quarter ended October 31, 2023, on Tuesday, December 12, 2023, after market close. The company offers end-to-end oncology solutions and will host a conference call to discuss the results at 4:30 P.M. EST (1:30 P.M. PST).
Positive
  • None.
Negative
  • None.

HACKENSACK, NJ / ACCESSWIRE / December 4, 2023 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the second quarter ended October 31, 2023, on Tuesday, December 12, 2023, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 589886. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 49578, or by accessing the investors section of the company's website within 72 hours.

About Champions Oncology, Inc.

Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.

SOURCE: Champions Oncology, Inc.



View source version on accesswire.com:
https://www.accesswire.com/813120/champions-oncology-to-announce-second-quarter-financial-results-on-tuesday-december-12-2023

FAQ

When will Champions Oncology, Inc. (CSBR) report its financial and operational results for the second quarter?

Champions Oncology, Inc. (CSBR) will report its financial and operational results for the second quarter ended October 31, 2023, on Tuesday, December 12, 2023, after market close.

What services does Champions Oncology, Inc. (CSBR) provide?

Champions Oncology, Inc. (CSBR) is a global preclinical and clinical research services provider that offers end-to-end oncology solutions.

When will the conference call to discuss the results take place?

The conference call to discuss the results will take place on Tuesday, December 12, 2023, at 4:30 P.M. EST (1:30 P.M. PST).

How can I join the conference call?

To join the call, dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 589886.

How can I access the replay of the call?

The replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 49578, or by accessing the investors section of the company's website within 72 hours.

Champions Oncology, Inc.

NASDAQ:CSBR

CSBR Rankings

CSBR Latest News

CSBR Stock Data

98.08M
10.01M
26.33%
49.09%
1.65%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BALTIMORE